USD 18.2
(-5.41%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 258.8 Million USD | -13.96% |
2022 | 300.8 Million USD | 14.03% |
2021 | 263.8 Million USD | -1.16% |
2020 | 266.9 Million USD | -3.96% |
2019 | 277.9 Million USD | -0.29% |
2018 | 278.7 Million USD | 1.09% |
2017 | 275.7 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 265.6 Million USD | 0.68% |
2024 Q2 | 263.8 Million USD | -1.35% |
2024 Q1 | 267.39 Million USD | 3.32% |
2023 Q2 | 297 Million USD | -3.32% |
2023 FY | 258.8 Million USD | -13.96% |
2023 Q4 | 258.8 Million USD | -7.17% |
2023 Q3 | 278.8 Million USD | -6.13% |
2023 Q1 | 307.2 Million USD | 2.13% |
2022 Q3 | 291.3 Million USD | 1.85% |
2022 Q2 | 286 Million USD | 2.0% |
2022 Q1 | 280.4 Million USD | 6.29% |
2022 FY | 300.8 Million USD | 14.03% |
2022 Q4 | 300.8 Million USD | 3.26% |
2021 Q3 | 274.3 Million USD | -11.94% |
2021 FY | 263.8 Million USD | -1.16% |
2021 Q1 | 283.2 Million USD | 6.11% |
2021 Q2 | 311.5 Million USD | 9.99% |
2021 Q4 | 263.8 Million USD | -3.83% |
2020 Q1 | 312.3 Million USD | 12.38% |
2020 FY | 266.9 Million USD | -3.96% |
2020 Q4 | 266.9 Million USD | 3.65% |
2020 Q3 | 257.5 Million USD | -8.3% |
2020 Q2 | 280.8 Million USD | -10.09% |
2019 Q2 | 279.7 Million USD | -1.96% |
2019 Q4 | 277.9 Million USD | -0.18% |
2019 Q3 | 278.4 Million USD | -0.46% |
2019 Q1 | 285.3 Million USD | 2.37% |
2019 FY | 277.9 Million USD | -0.29% |
2018 Q4 | 278.7 Million USD | 0.0% |
2018 FY | 278.7 Million USD | 1.09% |
2017 FY | 275.7 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alcon Inc. | 2.32 Billion USD | 88.851% |
AptarGroup, Inc. | 513.05 Million USD | 49.557% |
Baxter International Inc. | 2.82 Billion USD | 90.836% |
Becton, Dickinson and Company | 3.27 Billion USD | 92.093% |
Bausch + Lomb Corporation | 1.02 Billion USD | 74.825% |
Haemonetics Corporation | 317.2 Million USD | 18.412% |
ResMed Inc. | 822.25 Million USD | 68.525% |
Teleflex Incorporated | 626.21 Million USD | 58.672% |
Warby Parker Inc. | 62.23 Million USD | -315.85% |
West Pharmaceutical Services, Inc. | 434.7 Million USD | 40.465% |